logologo
QuantliQuantli

Allarity Therapeutics Inc

ALLR

NASDAQ

Biotechnology

$1.37

USD

+0.01 (+0.74%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $21.64M

Volume 45.5K

Price Target

$10.25$10.25

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $10.25 and a min estimate of $10.25.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$10.25

+$0.5 vs prior

Implied Upside

+648.2%

+36.5% vs prior

Analyst Covering

1

Unchanged vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

50%

A mix of recent and older ratings shape this consensus

Analyst Agreement

High

Targets are closely clustered - analysts largely agree

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Edward Woo

Ascendiant Capital

Buy

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

ACTU

Actuate Therapeutics Inc

$1.01

+3.6%

CELU

Celularity Inc

$0.7000

+0.1%

ABVC

ABVC Biopharma Inc

$0.9000

-6.2%

CLRB

Cellectar Biosciences Inc

$2.60

+4.8%

LGVN

Longeveron Inc

$0.7400

+6.1%

JSPR

Jasper Therapeutics Inc

$0.7900

-8.5%

NEUP

Neuphoria Therapeutics Inc

$3.87

+1.0%